✦ LIBER ✦

PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the Netherlands

✍ Scribed by A. Diamantopoulos; W. Kievit; R. De Vries; M. Pompen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (M

✍ R Plisko; J Krzystek; P Rys; M Russel-Szymczyk; M Szkultecka-Debek; K Szamotulsk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PMS49 COST-UTILITY ANALYSIS OF LEFLUNOMI

✍ Plisko, R; Krzystek, J; Lis, J; Rys, P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PMS70 COST-EFFECTIVENESS OF ETANERCEPT V

✍ X Gao; S Hwang; KT Carpiuc; JM Stephens; R Sato; A Singh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS26 COST-EFFECTIVENESS ANALYSIS OF RHB

✍ M Van Genugten; A Chhabra; V Alt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB